Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1
E M Migoya, R Bergeron, J L Miller, R N K Snyder, M Tanen, D Hilliard, B Weiss, P Larson, M Gutierrez, G Jiang, F. Liu, K A Pryor, J Yao, L Zhu, Jens Juul Holst, C Deacon, G Herman, N Thornberry, J Amatruda, D Williams-HermanJ A Wagner, R SinhaRoy
Dive into the research topics of 'Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1'. Together they form a unique fingerprint.